Long‐term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life-Reference-Cited by-同舟云学术

Long‐term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life

Published:2015-02-16 Issue:3 Volume:26 Page:171
ISSN:0959-4493
Container-title:Veterinary Dermatology
language:en
Short-container-title:Vet Dermatol

Author:

Cosgrove Sallie B.¹,Cleaver Dawn M.¹,King Vickie L.¹,Gilmer Amy R.¹,Daniels Anne E.¹,Wren Jody A.¹,Stegemann Michael R.²

Affiliation:

1. Zoetis Inc., Veterinary Medicine Research and Development 333 Portage Street Kalamazoo MI 49007 USA

2. Zoetis Inc., Veterinary Medicine Research and Development Mercuriusstraat 20 Zaventem B‐1930 Belgium

Publisher

Wiley

Subject

General Veterinary

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vde.12194

Reference25 articles.

1. Zoetis Online website.Apoquel®product label. Available at:https://www.zoetisus.com/bmst-minisite-apoquel/documents/finalapoquel_pi_8_5x11.pdf?utm_source=Prescribing&utm_medium=click&utm_campaign=Apoquelztssite. Accessed Jan 6 2015.

2. US Food and Drug Administration website.Apoquel FOI. Available at:http://www.fda.gov/downloads/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/UCM363901.pdf. Accessed Dec 09 2014.

3. Veterinary Drugs Directorate of Health Canada website.Apoquel. Available at:http://webprod5.hc-sc.gc.ca/noc-ac/index-eng.jsp. Accessed Jan 6 2015.[Note: Under Brand/Product Name type Apoquel and you will have a list of all strengths approved and the date of NOC.]

4. European Medicines Agency website.Apoquel. Available at:http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/veterinary/medicines/002688/vet_med_000280.jsp&mid=WC0b01ac058001fa1. Accessed Oct 9 2013.

5. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights on the in-vitro binding characteristics of human α-1-acid glycoprotein (HAG) with JAK inhibitor ocalcitinib: Multi-spectroscopic analysis combined with theoretical calculations;Journal of Molecular Structure;2024-08

2. Critically appraised topic: Benefits and risks of oclacitinib in treatment of allergic pruritus in dogs;Revue Vétérinaire Clinique;2024-06

3. Effects of a Protocol Combining a Non-Irritating Shampoo and an Adelmidrol-Based Adsorbent Mousse on Seborrhoea and Other Signs and Symptoms Secondary to Canine Atopic Dermatitis: A Multicenter, Open-Label Uncontrolled Clinical Trial;Veterinary Sciences;2024-05-21

4. Dog size and patterns of disease history across the canine age spectrum: Results from the Dog Aging Project;PLOS ONE;2024-01-17

5. Efficacy of Allogeneic and Xenogeneic Exosomes for the Treatment of Canine Atopic Dermatitis: A Pilot Study;Animals;2024-01-16